A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients by Francis Witz, Alain Sadoun, Marie-Claire Perrin, Christian Berthou, Jean Brière, Jean-Yves Cahn, Bruno Lioure, Brigitte Witz, Sylvie François, Bernard Desablens, Bernard Pignon, Pierre-Yves Le Prisé, Bruno Audhuy, Denis Caillot, Philippe Casassus, Martine Delain, Bernard Christian, Zéra Tellier, Valérie Polin, Patrick Hurteloup, and Jean-Luc Harousseau Blood Volume 91(8):2722-2730 April 15, 1998 ©1998 by American Society of Hematology
Francis Witz et al. Blood 1998;91:2722-2730 ©1998 by American Society of Hematology
Francis Witz et al. Blood 1998;91:2722-2730 ©1998 by American Society of Hematology
Francis Witz et al. Blood 1998;91:2722-2730 ©1998 by American Society of Hematology
Probability of OS among all eligible patients, according to assigned treatment group. Probability of OS among all eligible patients, according to assigned treatment group. Tick marks indicate surviving patients. Francis Witz et al. Blood 1998;91:2722-2730 ©1998 by American Society of Hematology